Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 3Completed 1

Sponsor Class

INDUSTRY 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3Neoplasm Metastasis 2

Interventions

Trastuzumab 78Capecitabine 59Cyclophosphamide 54Paclitaxel 52Docetaxel 50Letrozole 44Fulvestrant 43Lapatinib 34Doxorubicin 31Carboplatin 31Vinorelbine 30Bevacizumab 29Anastrozole 28pembrolizumab 26exemestane 24Tamoxifen 23Gemcitabine 22Radiotherapy 21Albumin-Bound Paclitaxel 19Taxes 17Everolimus 17Epirubicin 15pertuzumab 13Ado-Trastuzumab Emtansine 13130-nm albumin-bound paclitaxel 13palbociclib 12Magnetic Resonance Spectroscopy 12liposomal doxorubicin 11atezolizumab 11Filgrastim 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Breast Neoplasms × Biological Assay × Clear all
NCT00595023 2016-01-12

GeneSearch Breast Lymph Node (BLN) Assay Timing Study

Janssen Diagnostics, LLC

Terminated
233 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00595296 2016-01-12

GeneSearchâ„¢ Breast Lymph Node (BLN) Assay Post Approval Study

Janssen Diagnostics, LLC

Terminated
461 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00869674 2013-05-30

GeneSearchâ„¢ Breast Lymph Node (BLN) Assay China Registration Study

Johnson & Johnson Medical, China

Phase 3 Terminated
540 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡